Lonza Ltd Patents Larch Tree Arabinogalactan-Polyphenol Composition
Summary
The European Patent Office published patent application EP2638914A1 filed by Lonza Ltd, covering a composition comprising arabinogalactan and polyphenols derived from larch trees. The application, filed by inventors Freitas and Rodriguez, is classified under IPC codes A61K 36/13, A61P 31/00, and A61P 31/12, indicating therapeutic anti-infective applications. The patent designates all EU member states and additional European countries.
What changed
The EPO published patent application EP2638914A1 for Lonza Ltd, covering compositions containing arabinogalactan and polyphenols extracted from larch trees. The application is classified under IPC A61K 36/13 with therapeutic anti-infective designations (A61P 31/00, A61P 31/12). The patent designates all EU member states plus Switzerland, Norway, and other European countries.
For pharmaceutical and nutraceutical manufacturers developing immunomodulatory or anti-infective compositions, this patent establishes intellectual property protection around larch-derived arabinogalactan and polyphenol combinations. Companies in this space should assess whether their R&D activities may overlap with the claims in EP2638914A1 and consider freedom-to-operate analysis or licensing discussions with Lonza.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Composition comprising arabinogalactan and polyphenols from larch trees
Publication EP2638914A1 Kind: A1 Apr 08, 2026
Applicants
Lonza Ltd
Inventors
Freitas, Ulla, Rodriguez, Bryan
IPC Classifications
A61K 36/13 20060101AFI20260305BHEP A61P 31/00 20060101ALI20260305BHEP A61P 31/12 20060101ALI20260305BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.